146 related articles for article (PubMed ID: 34230159)
1. Pretreatment Absolute Lymphocyte Count and Neutrophil-to-lymphocyte Ratio Are Prognostic Factors for Stage III Breast Cancer.
Yamanouchi K; Maeda S; Takei D; Koga Y; Yamashita M; Hamada T; Hirayama T; Yoneda A; Tokunaga T; Takeshita H; Kuroki T
Anticancer Res; 2021 Jul; 41(7):3625-3634. PubMed ID: 34230159
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy.
Yildirim BA; Guler OC; Kose F; Onal C
J Obstet Gynaecol; 2019 Jul; 39(5):695-701. PubMed ID: 31023114
[TBL] [Abstract][Full Text] [Related]
3. Absolute Lymphocyte Count as an Independent Prognostic Factor in Metastatic Breast Cancer: A Retrospective Study.
Sawa A; Bando H; Kamohara R; Takeuchi N; Terasaki A; Okazaki M; Iguchi-Manaka A; Hara H
Oncology; 2022; 100(11):591-601. PubMed ID: 36099888
[TBL] [Abstract][Full Text] [Related]
4. Prediction of lymph node metastasis in oral tongue squamous cell carcinoma using the neutrophil-to-lymphocyte ratio and platelet-to-neutrophil ratio.
Wang B; Liu J; Zhong Z
J Clin Lab Anal; 2021 Jun; 35(6):e23684. PubMed ID: 33942387
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer.
Huang C; Yue J; Li Z; Li N; Zhao J; Qi D
Tumour Biol; 2015 Sep; 36(10):7581-9. PubMed ID: 25921282
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
Nakano K; Hosoda M; Yamamoto M; Yamashita H
Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment neutrophil-to-lymphocyte ratio predicts lymph node metastasis in triple-negative breast cancer.
Philip A; Jose M; Jose WM; Vijaykumar DK; Pavithran K
Indian J Cancer; 2022; 59(4):469-473. PubMed ID: 33753631
[TBL] [Abstract][Full Text] [Related]
8. Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial.
Tokunaga E; Miyoshi Y; Dozono K; Kawaguchi T; Toi M
Oncologist; 2024 Mar; 29(3):e319-e329. PubMed ID: 37971418
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
[TBL] [Abstract][Full Text] [Related]
10. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.
Jiang K; Lei J; Chen W; Gong Y; Luo H; Li Z; Gong R; Zhu J
Medicine (Baltimore); 2016 Oct; 95(40):e5079. PubMed ID: 27749581
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y
PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079
[TBL] [Abstract][Full Text] [Related]
12. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
13. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
[TBL] [Abstract][Full Text] [Related]
14. The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.
Kara M; Uysal S; Altinişik U; Cevizci S; Güçlü O; Dereköy FS
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):535-542. PubMed ID: 27520567
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer.
Ferroni P; Roselli M; Buonomo OC; Spila A; Portarena I; Laudisi A; Valente MG; Pirillo SP; Fortunato L; Costarelli L; Cavaliere F; Guadagni F
Anticancer Res; 2018 Aug; 38(8):4705-4712. PubMed ID: 30061239
[TBL] [Abstract][Full Text] [Related]
17. Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer.
Goto W; Kashiwagi S; Takada K; Asano Y; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
Anticancer Res; 2022 Feb; 42(2):939-946. PubMed ID: 35093893
[TBL] [Abstract][Full Text] [Related]
18. Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin.
Su MX; Lin HW; Nguyen HTH; Lin TC; Chen CJ; Wang HC; Wu CT; Wu YC; He GY; Liu LC; Huang CH
BMC Cancer; 2024 Feb; 24(1):195. PubMed ID: 38347468
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients.
Ijichi H; Tajiri W; Koi Y; Koga C; Nakamura Y; Okamoto M; Tokunaga E
J Surg Res; 2024 Apr; 296():98-105. PubMed ID: 38266423
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis.
Inari H; Teruya N; Kishi M; Horii R; Akiyama F; Takahashi S; Ito Y; Ueno T; Iwase T; Ohno S
BMC Cancer; 2020 Sep; 20(1):932. PubMed ID: 32993560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
